Yoram Bujanover

3.1k total citations
116 papers, 2.3k citations indexed

About

Yoram Bujanover is a scholar working on Surgery, Epidemiology and Genetics. According to data from OpenAlex, Yoram Bujanover has authored 116 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Surgery, 36 papers in Epidemiology and 29 papers in Genetics. Recurrent topics in Yoram Bujanover's work include Inflammatory Bowel Disease (23 papers), Microscopic Colitis (18 papers) and Eosinophilic Esophagitis (15 papers). Yoram Bujanover is often cited by papers focused on Inflammatory Bowel Disease (23 papers), Microscopic Colitis (18 papers) and Eosinophilic Esophagitis (15 papers). Yoram Bujanover collaborates with scholars based in Israel, United States and Germany. Yoram Bujanover's co-authors include Shimon Reif, Batia Weiss, Arie Levine, Fred M. Konikoff, Tuvia Gilat, Raanan Shamir, Y. Peled, Efrat Broide, Ram Reifen and Amit Assa and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Hepatology.

In The Last Decade

Yoram Bujanover

112 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoram Bujanover Israel 27 808 768 734 371 363 116 2.3k
David M. Israel Canada 24 829 1.0× 1.0k 1.4× 744 1.0× 425 1.1× 144 0.4× 66 2.1k
Alan M. Leichtner United States 32 1.4k 1.7× 846 1.1× 903 1.2× 695 1.9× 193 0.5× 87 3.1k
Adriana Marcheggiano Italy 26 1.0k 1.3× 995 1.3× 892 1.2× 579 1.6× 195 0.5× 66 2.4k
J Vilaseca Spain 22 623 0.8× 686 0.9× 514 0.7× 288 0.8× 229 0.6× 76 1.9k
Robert Burakoff United States 28 797 1.0× 953 1.2× 729 1.0× 322 0.9× 182 0.5× 82 2.4k
Adrian G. Thomas United Kingdom 28 777 1.0× 1.1k 1.4× 780 1.1× 495 1.3× 125 0.3× 74 2.8k
Jérôme Filippi France 21 729 0.9× 1.0k 1.4× 799 1.1× 467 1.3× 178 0.5× 58 2.1k
Russell S. Walmsley United Kingdom 14 577 0.7× 1.2k 1.6× 963 1.3× 337 0.9× 168 0.5× 22 2.1k
Bjarni Þjóðleifsson Iceland 28 1.1k 1.3× 412 0.5× 467 0.6× 757 2.0× 300 0.8× 77 2.4k
Wolfgang Petritsch Austria 27 638 0.8× 1.1k 1.4× 911 1.2× 374 1.0× 130 0.4× 86 2.2k

Countries citing papers authored by Yoram Bujanover

Since Specialization
Citations

This map shows the geographic impact of Yoram Bujanover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoram Bujanover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoram Bujanover more than expected).

Fields of papers citing papers by Yoram Bujanover

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoram Bujanover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoram Bujanover. The network helps show where Yoram Bujanover may publish in the future.

Co-authorship network of co-authors of Yoram Bujanover

This figure shows the co-authorship network connecting the top 25 collaborators of Yoram Bujanover. A scholar is included among the top collaborators of Yoram Bujanover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoram Bujanover. Yoram Bujanover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Almog, Tal, Gadi Shlomai, Iris Barshack, et al.. (2019). Interleukin-1α deficiency reduces adiposity, glucose intolerance and hepatic de-novo lipogenesis in diet-induced obese mice. BMJ Open Diabetes Research & Care. 7(1). e000650–e000650. 20 indexed citations
2.
Yanai, Henit, Lev Lichtenstein, Amit Assa, et al.. (2014). Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab. Clinical Gastroenterology and Hepatology. 13(3). 522–530.e2. 236 indexed citations
3.
Yanai, Henit, Lev Lichtenstein, Amit Assa, et al.. (2014). Su1121 Anti-TNF and Anti-Drug Antibodies Levels Predict the Outcomes of Interventions After Loss of Response to Adalimumab and Infliximab. Gastroenterology. 146(5). S–381. 1 indexed citations
4.
Roubenoff, Ronenn, Martin S. Obin, João D. Fontes, et al.. (2012). Plasma Pyridoxal-5-Phosphate Is Inversely Associated with Systemic Markers of Inflammation in a Population of U.S. Adults. Journal of Nutrition. 142(7). 1280–1285. 82 indexed citations
5.
Assa, Amit, Corina Hartman, Batia Weiss, et al.. (2012). Long-term outcome of tumor necrosis factor alpha antagonist's treatment in pediatric Crohn's disease. Journal of Crohn s and Colitis. 7(5). 369–376. 87 indexed citations
6.
Levine, Arie, Michal Kori, Gabriel Dinari, et al.. (2009). Comparison of two dosing methods for induction of response and remission with oral budesonide in active pediatric Crohnʼs disease: A randomized placebo-controlled trial. Inflammatory Bowel Diseases. 15(7). 1055–1061. 25 indexed citations
7.
Fidder, Herma H., Itay Maza, Arie Levine, et al.. (2009). Response to Medical Trestment in Patients With Crohn Disease: The Role of NOD2/CARD15 Mutations, Disease Phenotype and Age of Diagnosis. Journal of Pediatric Gastroenterology and Nutrition. 48(S2). 1 indexed citations
8.
Efrati, Ori, Meir Mei‐Zahav, Joseph Rivlin, et al.. (2006). Long Term Nutritional Rehabilitation by Gastrostomy in Israeli Patients with Cystic Fibrosis: Clinical Outcome in Advanced Pulmonary Disease. Journal of Pediatric Gastroenterology and Nutrition. 42(2). 222–228. 41 indexed citations
9.
Reifen, Ram, et al.. (2004). 5-ASA and lycopene decrease the oxidative stress and inflammation induced by iron in rats with colitis. Journal of Gastroenterology. 39(6). 514–519. 76 indexed citations
10.
Weiss, Batia, Raanan Shamir, Yoram Bujanover, et al.. (2004). NOD2/CARD15 mutation analysis and genotype-phenotype correlation in Jewish pediatric patients compared with adults with Crohn's disease. The Journal of Pediatrics. 145(2). 208–212. 36 indexed citations
11.
Zeitlin, Leonid, Murray B. Resnick, Fred M. Konikoff, et al.. (2003). DIVERGENT PATTERNS OF EXTRACELLULAR MATRIX PROTEIN EXPRESSION IN NEONATAL VERSUS ADULT LIVER FIBROSIS. Pediatric Pathology & Molecular Medicine. 22(4). 349–362. 2 indexed citations
12.
Levine, Arie, Zvi Weizman, Efrat Broide, et al.. (2003). A Comparison of Budesonide and Prednisone for the Treatment of Active Pediatric Crohn Disease. Journal of Pediatric Gastroenterology and Nutrition. 36(2). 248–252. 58 indexed citations
13.
Gorenstein, Arkadi, Francis Serour, & Yoram Bujanover. (1999). Unusual presentation of esophageal communicating duplication in a child. Journal of Pediatric Surgery. 34(9). 1430–1431. 8 indexed citations
14.
Bujanover, Yoram, Shimon Reif, & Jacob Yahav. (1996). HELICOBACTER PYLORI AND PEPTIC DISEASE IN THE PEDIATRIC PATIENT. Pediatric Clinics of North America. 43(1). 213–234. 46 indexed citations
15.
Moshkowitz, Menachem, Fred M. Konikoff, Yael Peled, et al.. (1996). One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients. Alimentary Pharmacology & Therapeutics. 10(6). 1015–1019. 29 indexed citations
16.
Arber, Nadir, Zvi Fireman, Arnon Lavie, et al.. (1995). A Controlled Double Blind Multicenter Study of the Effectiveness of 5-Aminosalicylic Acid in Patients with Crohnʼs Disease in Remission. Journal of Clinical Gastroenterology. 20(3). 203–206. 47 indexed citations
17.
Pittschieler, Klaus, Yoram Bujanover, Sergio Amarri, Emanuel Lebenthal, & James K. Petell. (1987). 93. DIFFERENTIAL REGULATION OF SOD1 AND SOD2 IN RAT LIVER DURING ONTOGENY. Pediatric Research. 22(1). 111–111. 2 indexed citations
18.
Bujanover, Yoram, et al.. (1985). Polymicrobial infection in campylobacter enteritis.. BMJ. 291(6496). 633–634. 6 indexed citations
19.
Peled, Y., et al.. (1985). The Development of Methane Production in Childhood and Adolescence. Journal of Pediatric Gastroenterology and Nutrition. 4(4). 575–579. 8 indexed citations
20.
Bujanover, Yoram, Peter Sullivan, William M. Liebman, Joseph R. Goodman, & Michael Thaler. (1979). Cholestyramine Treatment of Chronic Diarrhea Associated with Immune Deficiency Syndrome. Clinical Pediatrics. 18(10). 630–633. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David M. Israel Breakdown of academic impact, for papers by Alan M. Leichtner Breakdown of academic impact, for papers by Adriana Marcheggiano Breakdown of academic impact, for papers by J Vilaseca Breakdown of academic impact, for papers by Robert Burakoff Breakdown of academic impact, for papers by Adrian G. Thomas Breakdown of academic impact, for papers by Jérôme Filippi Breakdown of academic impact, for papers by Russell S. Walmsley Breakdown of academic impact, for papers by Bjarni Þjóðleifsson Breakdown of academic impact, for papers by Wolfgang Petritsch
Rankless by CCL
2026